Specific goal
|
To improve memory for medication taking |
To adapt the regimen to the patient's daily schedule to
address carelessness |
To avoid stopping the treatment when feeling better |
To avoid stopping the treatment when feeling worse |
|
Procedure 1
|
Procedure 2
|
Procedure 3
|
|
Provide an easy reminder and identify a daily
activity or cue that the patient does regularly at about the time he or
she should take medications and explain to the patient to take
medications at this time |
Explain fundamentals of hypertension and its management
to patient in terms he or she can understand. Explain how the medication
works in a simple way and what are the specific consequences or effects
if the patient stops taking it. |
Teach patient how to monitor the most common side effects
of his or her treatment (withdrawal rates due to side effects must be
investigated). Support and encourage patient to report the problem to the
physician. |
|
Therapeutic class information
|
Agents acting on the renin- angiotensin system, Beta blocking
agents and Calcium channel blockers
|
This medicines act by dilating the blood
vessels (and, in some cases*, reducing heart muscles contractility).
Therefore amlodipine and losartan may take a few weeks
to show noticeable effects. |
|
Linking medication taking to patient's daily schedule31
|
Withdrawal symptoms
|
Potential causes of withdrawal
|
Amlodipine |
Optimal dosing
time: in the morning, around breakfast time (there is little evidence of
what is the optimal time to take once-daily amlodipine, however the
optimal dosing time may be morning). |
Abrupt withdrawal of this agent can
precipitate coronary vasospasm, which may result in myocardial
infarction. |
Peripheral edema, fatigue, palpitation,
headache, dyspepsia, nausea. |
May be taken with food. |
Atenolol |
Optimal dosing
time: uncertain. |
Tachycardia, palpitation, excessive sweating,
chest pain, heart attack, death. |
Hypotension, bradycardia, bronchospasm, cold
extremities. |
May be taken with food (although the presence
of food may reduce the bioavailability of atenolol by 20%). |
Captopril |
Optimal dosing
time: uncertain (although there is fair evidence that bedtime dosing may
constitute an effective option to reduce cardiovascular risk) |
Abrupt withdrawal of these agents can
precipitate hypertensive rebound in diabetic patients with chronic renal
failure |
Dry cough, hyperkalemia (especially if used
with spironolactone; main symptoms: palpitations and muscle weakness),
postural hypotension. |
May be taken without food. |
Carvedilol |
Optimal dosing
time: evening. |
Tachycardia, palpitation, excessive sweating,
chest pain, heart attack, death. |
Fatigue, hypotension, diarrhea, asthenia,
bradycardia, dizziness, edema. |
May be taken with food. |
Enalapril |
Optimal dosing
time: evening. |
Abrupt withdrawal of these agents can
precipitate hypertensive rebound in diabetic patients with chronic renal
failure |
Hypotension, dry cough. |
May be taken with food. |
Losartan |
Optimal dosing
time: administration time-dependent effects of losartan have not been
documented. |
There is little evidence of rebound effect
after abrupt withdrawal of losartan therapy |
Dizziness, diarrhea, tiredness. |
May be taken with food (concurrent use of
losartan and grapefruit juice may result in increased half-life and
decreased area under the concentration time curve of losartan's active
metabolite). |
|
Therapeutic class information
|
Diuretics
|
These medications increase water loss by
inhibiting sodium and chloride resorption in the kidneys. When taking
these antihypertensives, one will urinate a lot because of the increased
water loss. |
|
Linking medication taking to patient's daily schedule
|
Withdrawal symptoms
|
Potential causes of withdrawal
|
Hydrochlorothiazide |
Optimal dosing
time: before 6 pm and preferably in the morning |
If diuretics are withdrawn suddenly in
patients with a normal sodium intake, there will be rebound retention of
sodium and water (with consequent edema), because compensatory mechanisms
that maintain sodium balance in the face of diuretics continue to act for
several days after diuresis has worn off. |
Hypokalemia (symptoms include muscular
weakness, myalgia, and muscle cramps), weakness. |
May be taken with food. |
Furosemide |
Optimal dosing
time: no significant difference related to dosing time was observed
between morning and evening trials. |
Hypokalemia (symptoms include muscular
weakness, myalgia, and muscle cramps), hyperglycemia, hyponatremia
(symptoms include nausea and vomiting, headache, fatigue, appetite
loss). |
May be taken with food. |
Spironolactone |
Optimal dosing
time: administration time-dependent effects of spironolactone have not
been documented. |
There is no apparent rebound effect after
abrupt withdrawal of spironolactone therapy |
Hyperkalemia (main symptoms: palpitations and
muscle weakness). |
May be taken with food. |
|
Therapeutic class information
|
Platelet aggregation inhibitors
|
Treatment with blood thinners prevents blood
clots from forming in blood vessels. It may be used to prevent or treat
heart attacks and stroke. |
|
Linking medication taking to patient's daily schedule
|
Withdrawal symptoms
|
Potential causes of withdrawal
|
Acetylsalicylic acid |
Optimal dosing time: in the morning and/or in
the evening with food (bedtime administration of aspirin decreases
morning surge of platelet aggregation while kept same antiplatelet
efficacy during other time of the day compared to taking these drugs at
day-time). |
The withdrawal of acetylsalicylic acid may be associated
with traditional cardiovascular risk factors and thrombosis. |
Gastrointestinal side effects (pain, heartburn,
indigestion), bleeding. |
Clopidogrel |
Optimal dosing time: in the morning and/or in
the evening with food (bedtime administration of clopidogrel decreases
morning surge of platelet aggregation while kept same antiplatelet
efficacy during other time of the day compared to taking these drugs at
day-time). |
Clopidogrel withdrawal is associated with a rebound
prothrombotic and/ or proinflammatory response. Premature cessation of
clopidogrel in patients receiving drug-eluting stents is a clear risk
factor for stent thrombosis. |
Bleeding, Gastrointestinal side effects (pain, heartburn,
indigestion, diarrhea), rash. |
|
Therapeutic class information
|
Lipid modifying agent
|
These agents are used along with a proper
diet to help lower 'bad' cholesterol and fats and raise 'good'
cholesterol in the blood |
|
Linking medication taking to patient's daily schedule
|
Withdrawal symptoms
|
Potential causes of withdrawal
|
Rosuvastatin |
Optimal dosing
time: in the morning or in the evening (there are sufficient data to
support evening administration of simvastatin to achieve optimal effect,
however the elimination half-life of rosuvastatin is significantly longer
and this is probably significant in the ability to take it in the morning
with non-significant changes in lipid lowering compared to evening
administration). |
Statin withdrawal abrogates this beneficial
effect in patients initially responsive to this therapy and may cause
rebound inflammatory effect. |
Muscle pain, fatigue and weakness, myalgia,
cognitive loss. |
May be taken without food. |